Genomma Lab to Host 2026 Investor Day in New York

MEXICO CITY, Oct. 15, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Latin America with operations in 18 countries, today announced that it will host its 2026 Investor Day on Thursday, December 3, 2026, in New York, NY.

During the event, Genomma Lab's senior management team will provide an update on the Company's strategic priorities, growth opportunities and new operational platform, including the role of artificial intelligence in driving innovation and operational execution. The event will also feature demonstrations of AI agents and their applications across the business.

The event will be held in person for institutional investors and sell-side analysts, and pre-registration is required by November 25, 2026.

To register, please click here. Confirmed attendees will receive additional event details.

For more information, please contact InspIR Group at [email protected] or Genomma Lab at [email protected].

About Genomma Lab Internacional 
Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Latin America. Genomma Lab develops, sells and markets a broad range of Premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has a sound business model through a unique combination of a new product development process, consumer oriented marketing, a broad retail distribution network and a low‐cost, highly flexible supply chain operating model. For more information visit: www.genommalab.com. Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM).

Note on Forward-Looking Statements
This press release may contain forward-looking statements regarding Genomma Lab Internacional, S.A.B. de C.V., including statements concerning the Company's strategy, business plans, growth opportunities, operational initiatives and future performance. These statements reflect management's current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, among others, changes in economic and market conditions, foreign exchange rate fluctuations, competitive pressures, regulatory developments, supply chain disruptions, changes in consumer behavior and the Company's ability to execute its strategic initiatives. Additional information regarding risks and uncertainties affecting the Company is available in its filings with the Bolsa Mexicana de Valores. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update or revise them, except as required by applicable law.

SOURCE Genomma Lab Internacional, S.A.B. de C.V.